塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/05/21 | 5,750 | 5,786 | 5,733 | 5,748 | -9 | -0.2% | 898,000 |
2018/05/18 | 5,777 | 5,777 | 5,725 | 5,757 | +3 | +0.1% | 1,004,800 |
2018/05/17 | 5,748 | 5,776 | 5,729 | 5,754 | +26 | +0.5% | 977,500 |
2018/05/16 | 5,704 | 5,737 | 5,690 | 5,728 | +5 | +0.1% | 790,100 |
2018/05/15 | 5,679 | 5,754 | 5,643 | 5,723 | -4 | -0.1% | 1,113,000 |
2018/05/14 | 5,747 | 5,763 | 5,719 | 5,727 | -13 | -0.2% | 980,100 |
2018/05/11 | 5,675 | 5,747 | 5,665 | 5,740 | +72 | +1.3% | 1,623,400 |
2018/05/10 | 5,577 | 5,677 | 5,510 | 5,668 | +191 | +3.5% | 1,716,600 |
2018/05/09 | 5,560 | 5,620 | 5,428 | 5,477 | -208 | -3.7% | 2,387,000 |
2018/05/08 | 5,603 | 5,699 | 5,602 | 5,685 | +34 | +0.6% | 1,044,500 |
2018/05/07 | 5,629 | 5,660 | 5,536 | 5,651 | -8 | -0.1% | 1,367,300 |
2018/05/02 | 5,687 | 5,690 | 5,606 | 5,659 | +3 | +0.1% | 1,508,600 |
2018/05/01 | 5,650 | 5,712 | 5,638 | 5,656 | +22 | +0.4% | 1,522,200 |
2018/04/27 | 5,630 | 5,660 | 5,617 | 5,634 | +54 | +1% | 1,037,500 |
2018/04/26 | 5,637 | 5,639 | 5,560 | 5,580 | -57 | -1% | 1,610,000 |
2018/04/25 | 5,617 | 5,665 | 5,576 | 5,637 | +19 | +0.3% | 1,187,000 |
2018/04/24 | 5,563 | 5,643 | 5,536 | 5,618 | +108 | +2% | 1,310,400 |
2018/04/23 | 5,512 | 5,535 | 5,478 | 5,510 | +13 | +0.2% | 840,400 |
2018/04/20 | 5,501 | 5,533 | 5,467 | 5,497 | -18 | -0.3% | 1,269,800 |
2018/04/19 | 5,584 | 5,597 | 5,508 | 5,515 | -35 | -0.6% | 1,022,500 |
2018/04/18 | 5,535 | 5,577 | 5,511 | 5,550 | +14 | +0.3% | 913,400 |
2018/04/17 | 5,496 | 5,554 | 5,486 | 5,536 | +17 | +0.3% | 907,100 |
2018/04/16 | 5,445 | 5,521 | 5,416 | 5,519 | +83 | +1.5% | 899,500 |
2018/04/13 | 5,450 | 5,478 | 5,401 | 5,436 | -61 | -1.1% | 1,393,800 |
2018/04/12 | 5,467 | 5,531 | 5,462 | 5,497 | -4 | -0.1% | 915,800 |
2018/04/11 | 5,530 | 5,553 | 5,471 | 5,501 | -81 | -1.5% | 1,030,800 |
2018/04/10 | 5,611 | 5,669 | 5,541 | 5,582 | -58 | -1% | 1,416,800 |
2018/04/09 | 5,590 | 5,652 | 5,570 | 5,640 | +44 | +0.8% | 968,400 |
2018/04/06 | 5,523 | 5,617 | 5,476 | 5,596 | +45 | +0.8% | 1,585,300 |
2018/04/05 | 5,485 | 5,605 | 5,446 | 5,551 | +137 | +2.5% | 1,871,100 |
2018/04/04 | 5,470 | 5,475 | 5,363 | 5,414 | -49 | -0.9% | 1,724,000 |
2018/04/03 | 5,400 | 5,487 | 5,361 | 5,463 | +10 | +0.2% | 1,483,800 |
2018/04/02 | 5,480 | 5,515 | 5,450 | 5,453 | -38 | -0.7% | 994,300 |
2018/03/30 | 5,526 | 5,527 | 5,461 | 5,491 | +6 | +0.1% | 973,000 |
2018/03/29 | 5,508 | 5,526 | 5,439 | 5,485 | +38 | +0.7% | 1,169,600 |
2018/03/28 | 5,328 | 5,450 | 5,323 | 5,447 | -3 | -0.1% | 1,317,600 |
2018/03/27 | 5,390 | 5,461 | 5,367 | 5,450 | +93 | +1.7% | 1,958,700 |
2018/03/26 | 5,200 | 5,357 | 5,200 | 5,357 | +135 | +2.6% | 2,363,800 |
2018/03/23 | 5,302 | 5,358 | 5,206 | 5,222 | -232 | -4.3% | 2,698,500 |
2018/03/22 | 5,391 | 5,454 | 5,383 | 5,454 | +53 | +1% | 1,628,500 |
2018/03/20 | 5,400 | 5,483 | 5,392 | 5,401 | -20 | -0.4% | 1,411,900 |
2018/03/19 | 5,468 | 5,485 | 5,409 | 5,421 | -64 | -1.2% | 911,900 |
2018/03/16 | 5,544 | 5,544 | 5,458 | 5,485 | -21 | -0.4% | 1,771,400 |
2018/03/15 | 5,569 | 5,579 | 5,493 | 5,506 | -57 | -1% | 1,244,900 |
2018/03/14 | 5,571 | 5,572 | 5,531 | 5,563 | -9 | -0.2% | 1,129,200 |
2018/03/13 | 5,507 | 5,576 | 5,492 | 5,572 | +29 | +0.5% | 804,400 |
2018/03/12 | 5,658 | 5,658 | 5,521 | 5,543 | -33 | -0.6% | 1,158,000 |
2018/03/09 | 5,630 | 5,686 | 5,537 | 5,576 | +31 | +0.6% | 2,286,300 |
2018/03/08 | 5,573 | 5,593 | 5,516 | 5,545 | +112 | +2.1% | 1,846,900 |
2018/03/07 | 5,433 | 5,505 | 5,394 | 5,433 | -50 | -0.9% | 1,669,600 |
1701~
1750
件表示中 / 3695件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 240,500円 | +5.7% | +3.9% | 2.55% | 11.97倍 | 1.58倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 707,500円 | +2.2% | +10.2% | 1.70% | 13.59倍 | 1.37倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 139,600円 | +0.9% | +380.2% | 5.59% | 19.23倍 | 1.65倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
エーザイ | 405,000円 | +1.7% | -2.9% | 3.95% | 26.57倍 | 1.39倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
協和キリン | 220,400円 | -3.5% | -11.3% | 2.72% | 20.24倍 | 1.36倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム